Category:Sympathomimetics: Difference between revisions

The boundary of this category is "medicine whose principal action is agonism of adrenergic receptors, directly or indirectly." The non-catecholamine medicines that block these receptors (the [[:Category:Beta-blockers|beta-blockers]], the [[:Category:Alpha-1_blockers|alpha-1 blockers]]) are the opposite of sympathomimetics and are collected under their own categories. The serotonin- and noradrenaline-reuptake inhibitors used as antidepressants (venlafaxine, duloxetine) and the noradrenaline-reuptake-inhibitor ADHD medicine atomoxetine have indirect sympathomimetic properties but are classified by their psychiatric indication. The opioid agonist meperidine has weak amphetamine-like central stimulant properties on its normeperidine metabolite but is not a sympathomimetic in any clinically meaningful sense. The [[:Category:Antimigraine_agents|triptans]] act on 5-HT1B/1D receptors of cranial vasculature and are sometimes mistakenly described as sympathomimetic; they are not, and are collected under [[:Category:Triptans|triptans]].